VivoSim Labs (VIVS) Stock: Buy, Sell, or Hold?

VIVS - VivoSim Labs, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$0.21
0.01 (5.09%) ▲
5d: -6.27%
30d: -26.02%
90d: -77.17%
HOLD
MODERATE Confidence
Analysis Updated: Oct 5, 2026 12:00 AM ET
Earnings: Nov 05, 2026 29d

Get Alerted When VIVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: VIVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: VIVS is currently trading at $0.21, which is considered oversold relative to its 30-day fair value range of $0.23 to $0.29.

Technical Outlook: Technically, VIVS is in a strong downtrend. Immediate support is located at $0.19, while resistance sits at $0.26. The stock is showing strong short-term momentum, up 5.1% recently.

Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.23 - $0.29
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (58/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.1%)
  • NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
  • CAUTION: 5-day price weakness (-6.3%) - monitor closely

Trading Range Analysis

30-Day Trading Range $0.23 - $0.29
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.19
Resistance Level $0.26
Current Trend Strong Downtrend
Technical data as of Oct 5, 2026

Fundamental Context

Revenue Growth (YoY) -51.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 06, 2026 12:55 AM ET
Data refreshes hourly during market hours. Next update: 1:55 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VIVS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ASND
Ascendis Pharma AS
STRONG BUY
20 analysts
$307 68 BUY
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$433 48 HOLD
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
29 analysts
$371 41 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
STOK
Stoke Therapeutics Inc
STRONG BUY
14 analysts
$46 67 BUY

More Analysis for VIVS

VIVS Technical Chart VIVS Price Prediction VIVS Earnings Date VIVS Investment Advisor VIVS Fair Price Analyzer VIVS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals